Cognition Therapeutics Inc Capital Reinvestment Ratio

Latest as of December 2021: 0.27x

Cognition Therapeutics Inc capital reinvestment ratio. Cognition Therapeutics Inc (CGTX) has a Capital Reinvestment Ratio of 0.27x as of December 2021, meaning it reinvests 0% of its operating cash flow ($101.00K) in capital expenditures ($27.00K). Check Cognition Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.27x

Capex / Operating Cash Flow

Operating Cash Flow

$101.00K

USD

Capital Expenditures

$27.00K

USD

Data as of

Dec 2021

Most recent filing

Cognition Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Cognition Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of Cognition Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow